U.S. FDA approves Sanofi's MS drug Lemtrada

November 15, 2014 3:23 PM

10 0

PARIS (Reuters) - The U.S. Food and Drug Administration has approved Sanofi's multiple sclerosis treatment Lemtrada, Sanofi said in a statement on Saturday.

Lemtrada is already sold in Europe but last December U.S. regulators rejected it on security concerns, prompting analysts to slash their global sales forecasts for the drug.

Also read: Kevin Durant plans to opt out of contract with Golden State Warriors

Read more

To category page